[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"norm-eurlex-reg_2012_823-art-2-de":3},{"law":4,"norm_id":14,"norm_key":15,"slug":16,"title":17,"chapter":18,"content":19,"enriched_content":20,"hierarchy":21,"neighbors_before":22,"neighbors_after":33,"citing_decisions":34,"is_thin":35},{"abbreviation":5,"title":6,"source_type":7,"jurisdiction":8,"document_kind":9,"language":10,"attribution":11,"version_date":12,"source_url":13},"reg_2012_823","zur Festlegung von von der Durchführungsverordnung (EU) Nr. 540\u002F2011 abweichenden Fristen für die Genehmigung der Wirkstoffe 2,4-DB, Benzoesäure, beta-Cyfluthrin, Carfentrazon-ethyl, Coniothyrium minitans Stamm CON\u002FM\u002F91-08 (DSM 9660), Cyazofamid, Cyfluthrin, Deltamethrin, Dimethenamid-P, Ethofumesat, Ethoxysulfuron, Fenamidon, Flazasulfuron, Flufenacet, Flurtamon, Foramsulfuron, Fosthiazat, Imazamox, Iodosulfuron, Iprodion, Isoxaflutol, Linuron, Maleinsäurehydrazid, Mecoprop, Mecoprop-P, Mesosulfuron, Mesotrion, Oxadiargyl, Oxasulfuron, Pendimethalin, Picoxystrobin, Propiconazol, Propineb, Propoxycarbazon, Propyzamid, Pyraclostrobin, Silthiofam, Trifloxystrobin, Warfarin und Zoxamid","eurlex","eu","regulation","de","© Europäische Union, https:\u002F\u002Feur-lex.europa.eu","2025-07-12","https:\u002F\u002Feur-lex.europa.eu\u002Flegal-content\u002FDE\u002FALL\u002F?uri=CELEX:32012R0823",7020894,"Art. 2","art-2","Inkrafttreten",null,"Diese Verordnung tritt am zwanzigsten Tag nach ihrer Veröffentlichung im Amtsblatt der Europäischen Union in Kraft.","REG_2012_823 - Art. 2 Inkrafttreten\n\nDiese Verordnung tritt am zwanzigsten Tag nach ihrer Veröffentlichung im Amtsblatt der Europäischen Union in Kraft.",{},[23,27,30],{"norm_key":24,"title":25,"slug":26},"Art. 1","Befristungen","art-1",{"norm_key":28,"title":18,"slug":29},"ErwGr. 5","erwgr-5",{"norm_key":31,"title":18,"slug":32},"ErwGr. 4","erwgr-4",[],[],true]